Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial
| Status: | Enrolling by invitation |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/23/2018 |
| Start Date: | December 21, 2017 |
| End Date: | August 31, 2020 |
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination
HPV vaccine coverage among adolescents in the US is suboptimal. This is particularly true
among traditionally underserved adolescents. Few parent-targeted interventions have focused
on the parental decision-making process. Self-persuasion, generating one's own arguments for
engaging in a behavior, may be an effective means to influence parents' motivation to
vaccinate their children. In a three-phase study, investigators are using quantitative and
qualitative research methods to develop and refine a tablet-based self-persuasion
intervention for parents who are undecided about the HPV vaccine. This clinical trial
submission focuses on the third phase of the study (the second stage is also registered in
clinical trials).
among traditionally underserved adolescents. Few parent-targeted interventions have focused
on the parental decision-making process. Self-persuasion, generating one's own arguments for
engaging in a behavior, may be an effective means to influence parents' motivation to
vaccinate their children. In a three-phase study, investigators are using quantitative and
qualitative research methods to develop and refine a tablet-based self-persuasion
intervention for parents who are undecided about the HPV vaccine. This clinical trial
submission focuses on the third phase of the study (the second stage is also registered in
clinical trials).
Despite the fact that HPV vaccination is recommended for male and female adolescents, HPV
vaccine coverage among adolescents age 13-17 is poor (60% for girls, 41.7% for boys).
HPV-related cancers are a significant burden on the US healthcare system and could be
prevented through adolescent vaccination. Rates of vaccination are suboptimal among
underserved populations (uninsured, low-income, racial and ethnic minorities) often seen in
safety-net clinics. Few interventions have been designed that target decision-making among
parents of unvaccinated adolescents. Self-persuasion, generating of one's own arguments for a
health behavior, may be an effective means of influencing HPV vaccination behaviors among
undecided or ambivalent parents. Through three stages, investigators will identify and
develop a self-persuasion intervention strategy to promote adolescent HPV vaccination in
safety-net clinics. In Stage 3, reported here, investigators will conduct a two-arm pilot
randomized control trial in the safety-net clinics to assess feasibility of testing the
self-persuasion intervention condition against standard of care (control group).
Investigators will also examine the impact of the intervention on parent-provider discussions
about HPV vaccination.
vaccine coverage among adolescents age 13-17 is poor (60% for girls, 41.7% for boys).
HPV-related cancers are a significant burden on the US healthcare system and could be
prevented through adolescent vaccination. Rates of vaccination are suboptimal among
underserved populations (uninsured, low-income, racial and ethnic minorities) often seen in
safety-net clinics. Few interventions have been designed that target decision-making among
parents of unvaccinated adolescents. Self-persuasion, generating of one's own arguments for a
health behavior, may be an effective means of influencing HPV vaccination behaviors among
undecided or ambivalent parents. Through three stages, investigators will identify and
develop a self-persuasion intervention strategy to promote adolescent HPV vaccination in
safety-net clinics. In Stage 3, reported here, investigators will conduct a two-arm pilot
randomized control trial in the safety-net clinics to assess feasibility of testing the
self-persuasion intervention condition against standard of care (control group).
Investigators will also examine the impact of the intervention on parent-provider discussions
about HPV vaccination.
Inclusion Criteria:
- Undecided parents of 11-17 year old patients who have not begun the HPV vaccine
series.
Exclusion Criteria:
- Pregnant adolescents
- Having impairing hearing or speech
- Phase 1 and 2 participants will be excluded from participation this trial
We found this trial at
1
site
U.T. Southwestern Medical Center The story of UT Southwestern Medical Center is one of commitment...
Click here to add this to my saved trials
